Æ÷½ºÅÍ ¹ßÇ¥
Cambridge Healthtech Institute´Â Æ÷½ºÅÍ ¼¼¼Ç¿¡¼ ÀÚ½ÅÀÇ ¿¬±¸ ¼º°ú¸¦ ¹ßÇ¥ÇÏ´Â °ÍÀ¸·Î »õ·Î¿î ÁÖ¸ñÀ» ¹Þ´Â °ÍÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ÇöÀå¿¡¼ ÀÚ½ÅÀÇ Æ÷½ºÅÍ¿ëÀ¸·Î Æ÷½ºÅÍ º¸µå¸¦ È®º¸Çϰí, Æ÷½ºÅͰ¡ ÄÁÆÛ·±½º ÀÚ·á¿¡ È®½ÇÈ÷ °ÔÀçµÇµµ·Ï Çϱâ À§Çؼ´Â 2025³â 10¿ù 10ÀϱîÁö Æ÷½ºÅÍ Á¦Ãâ ÀÚ·á°¡ ¼ö¸®µÇ°í, µî·Ïºñ¸¦ Àü¾× °áÁ¦ÇØ¾ß ÇÕ´Ï´Ù.
µî·Ï°ú ÇÔ²² Æ÷½ºÅÍ ¹ßÇ¥¸¦ Èñ¸ÁÇÏ´Â ÃëÁö¸¦ ¾Ë·ÁÁֽñ⠹ٶø´Ï´Ù. µî·Ï 󸮰¡ ¿Ï·áµÇ¸é ÀÚ·á Á¦Ãâ ¹æ¹ý¿¡ °üÇÑ ¸µÅ©¿Í ÀÚ·á Á¦Ãâ ÀýÂ÷°¡ ±âÀçµÈ À̸ÞÀÏÀ» º¸³»µå¸³´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¾Æ·¡¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
ÀÌ ÄÁÆÛ·±½º¿¡¼ ¿¬±¸ Æ÷½ºÅ͸¦ ¹ßÇ¥ÇØ¾ß ÇÏ´Â ÀÌÀ¯ :
- ¿¬±¸´Â Á¦¾à, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö, Çмú±â°ü, Á¤ºÎ±â°üÀÇ Å¾ ¸®´õ·Î ±¸¼ºµÈ ±¹Á¦ ´ëÇ¥´ÜÀÌ º¼ ¼ö ÀÖ½À´Ï´Ù.
- ÀÚ½ÅÀÇ ¿¬±¸¿¡ ´ëÇØ ´Ù¸¥ Âü°¡ÀÚ¿Í ³íÀÇÇϰí, Çù¾÷ÇÒ ¼ö ÀÖ½À´Ï´Ù.
- Æ÷½ºÅÍ ¹ßÇ¥ ³»¿ëÀº ÄÁÆÛ·±½º ÀÚ·á¿¡ °ÔÀçµË´Ï´Ù.
- µî·Ïºñ°¡ 50À¯·Î ÇÒÀÎ
Æ÷½ºÅÍ ¸¶°¨ÀϱîÁö ´ÙÀ½ Æ÷½ºÅÍ ¹ßÇ¥ ÀڷḦ Á¦ÃâÇØ ÁֽʽÿÀ. :
- Æ÷½ºÅÍ Å¸ÀÌÆ²
- °ÔÀç¿ë ªÀº ÅØ½ºÆ®·Î¸¸ ±¸¼ºµÈ ¼³¸í¹®(70 words, 500 ¹®ÀÚ Á¤µµ)
- ÄÁÆÛ·±½º ÀÚ·á¿ë µðÁöÅÐ Æ÷½ºÅÍ(1ÆäÀÌÁö, À½¼º ¾ø´Â PDF Æ÷½ºÅÍ)
´ë¸é Âü°¡ÀÚ´Â ÇöÀå ¿¶÷¿ëÀ¸·Î 1ÆäÀÌÁöÀÇ ÀÎ¼â Æ÷½ºÅ͸¦ ÁöÂüÇÒ ¼öµµ ÀÖ½À´Ï´Ù.
ÀÎ¼â Æ÷½ºÅÍ´Â ¼¼·ÎÇüÀ¸·Î, ISO ¿ëÁö A0 »çÀÌÁî, Æø 841mm x ³ôÀÌ 1,189 mm(¶Ç´Â Æø 33.11ÀÎÄ¡ x ³ôÀÌ 46.81ÀÎÄ¡)ÀÔ´Ï´Ù.
ÇöÀå¿ë Æ÷½ºÅÍ´Â À̺¥Æ®ÀÇ ÀϺο¡¸¸ °Ô½ÃµÉ ¼ö ÀÖ½À´Ï´Ù. Á¦Ãâ½Ã Æ÷½ºÅÍ ÇÁ·Î±×·¥ÀÇ ¼±ÅÃÀ» ¸í½ÃÇØ ÁֽʽÿÀ. Çʿ信 µû¶ó Âü°¡ÀÚ¿Í Á¤¿øÀÇ ¿ä°ÇÀ» °í·ÁÇÏ¿© Æ÷½ºÅ͸¦ º°µµ ¼¼¼Ç¿¡ Àç¹èÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù.
** ¸ðµç Æ÷½ºÅÍ ¹ßÇ¥ÀÚ´Â °¡»ó Ç÷§Æû¿ëÀ¸·Î 1ÆäÀÌÁöÀÇ À½¼º ¾ø´Â PDF Æ÷½ºÅͰ¡ ÇÊ¿äÇÕ´Ï´Ù.
Æ÷½ºÅÍ ½ºÆäÀ̽º¿¡´Â ÇѰ谡 ÀÖ½À´Ï´Ù. ÀÌ À̺¥Æ® Æ÷½ºÅÍ´Â 1¸í´ç 1¸ÅÀÔ´Ï´Ù. Æ÷½ºÅÍ ¸Å¼ö´Â ±â¾÷¿¡ µû¶ó Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ºü¸¥ Á¦ÃâÀ» ÃßõÇÕ´Ï´Ù.
Cambridge Healthtech Institute´Â ¹Ì·¡ÀÇ °úÇÐÀÚ¸¦ Áö¿øÇϰí, Æò°¡ÇÒ ¼ö ÀÖ´Â °ÍÀ» ÀÚ¶û½º·´°Ô »ý°¢ÇÕ´Ï´Ù!
**ǮŸÀÓ ´ëÇпø»ý¡¤¹Ú»ç °úÁ¤ ÇлýÀº Çлý ¿ä±Ý ´ë»óÀÔ´Ï´Ù. ÇлýÀº ¿¬±¸ Æ÷½ºÅÍ ¹ßÇ¥¸¦ ±ÇÀåÇϰí ÀÖ½À´Ï´Ù.
- Æ÷½ºÅÍ ¹ßÇ¥ ½½·ÔÀ» ȹµæÇϰí, µî·Ïºñ ÇÒÀÎÀ» ¹Þ½À´Ï´Ù.
- ¿©·¯ºÐÀÇ Æ÷½ºÅ͸¦ Á¦¾à, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö, Çмú±â°ü, Á¤ºÎ±â°üÀÇ Å¾ ¸®´õ·Î ±¸¼ºµÈ ±¹Á¦ ´ëÇ¥´Ü¿¡°Ô ¹ßÇ¥ÇÒ ¼ö ÀÖ½À´Ï´Ù.
- ÀáÀçÀû °í¿ëÁÖ ¹× Àθưú ³×Æ®¿öÅ©¸¦ ±¸ÃàÇϰí, ¿¬±¸¸¦ ÇÑÃþ ´õ ÁøÇàÇϰí Çù¾÷À» Çü¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù.
Æ÷½ºÅÍ °ø¸ðÀü
PEGS Europe¿¡¼ Æ÷½ºÅ͸¦ ¹ßÇ¥Çϸé ÀÚµ¿À¸·Î ÀÀ¸ðµË´Ï´Ù. ¼ö»óÀڴ ªÀº ÅØ½ºÆ® ¼³¸íÀÇ ¸í·á¼º, µ¥ÀÌÅÍÀÇ Âü½Å¼º, ¹ßÇ¥µÈ ¿¬±¸ ±â¼úÀÇ Áøº¸ ¹× ÀǹÌ, Æ÷½ºÅÍ ¹ßÇ¥ÀÇ ½Ã°¢Àû ¸íÈ®¼º, ¸Å·ÂÀûÀÎ ±¸µÎ ¼³¸í¿¡ ±â¹ÝÇÏ¿© ¼±Á¤µË´Ï´Ù.
¹ßÇ¥ ³»¿ëÀº °úÇÐÀûÀ̸ç ÄÁÆÛ·±½º ÅäÇÈ¿¡ °ü·ÃµÈ °ÍÀ̾î¾ß ÇÕ´Ï´Ù. ±¤°í ¹× ±ÇÀ¯´Â ½ÂÀεÇÁö ¾Ê½À´Ï´Ù.
Cambridge Healthtech Institute´Â Æ÷½ºÅÍ ³»¿ëÀ» °¢Á¾ ¸¶ÄÉÆÃ ÀÚ·á ¹× Á¦Ç°¿¡ °ÔÀçÇÒ ±Ç¸®¸¦ °¡Áý´Ï´Ù.
ÀÚ¼¼ÇÑ »çÇ×Àº (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼ÇÀ¸·Î ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù.
ÄÁÆÛ·±½º ÇÁ·Î±×·¥

°øÇÐ ½ºÆ®¸²
- Display of Biologics
¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ µð½ºÇ÷¹ÀÌ - Engineering Antibodies
Ç×ü °øÇÐ - Machine Learning Part 2
±â°èÇнÀ ÆÄÆ® 2

Ÿ°Ù ½ºÆ®¸²
- Antibody-Based Therapies
Ç×ü ±â¹Ý ÀǾà - Emerging Targets
½Å±Ô Ÿ°Ù - Membrane Protein Targets
¸·´Ü¹éÁú Ÿ°Ù

ÀÌÁ߯¯À̼º ½ºÆ®¸²
- Safety & Efficacy
¾ÈÀü¼º¡¤À¯È¿¼º - Advancing Multispecifics
´ÙÁß Æ¯À̼º Ç×üÀÇ Áøº¸ - Engineering Bispecifics
ÀÌÁ߯¯À̼ºÇ×ü °øÇÐ

¸é¿ªÄ¡·á ½ºÆ®¸²
- Immunoengineering
¸é¿ª °øÇÐ - Innovative CAR Therapy
Çõ½ÅÀûÀÎ CAR ¿ä¹ý - Next-Gen Immunotherapies
Â÷¼¼´ë ¸é¿ªÄ¡·á

ºÐ¼®¹ý ½ºÆ®¸²
- Optimisation & Developability
ÃÖÀûÈ¡¤°³¹ß °¡´É¼º - Analytical Characterisation
ºÐ¼®¹ý Ư¼º Æò°¡ - Protein Stability & Formulation
´Ü¹éÁú ¾ÈÁ¤¼º¡¤Á¦Çü

¹ßÇö ½ºÆ®¸²
- Leveraging Data Science
µ¥ÀÌÅÍ »çÀ̾𽺠Ȱ¿ë - Optimising Expression
¹ßÇö ÃÖÀûÈ - Developing Workflows
¿öÅ©ÇÃ·Î¿ì °³¹ß

±â°èÇнÀ ½ºÆ®¸²
- Intro to Machine Learning
±â°èÇнÀ ÀÔ¹® - Machine Learning Part 1
±â°èÇнÀ ÆÄÆ® 1 - Machine Learning Part 2
±â°èÇнÀ ÆÄÆ® 2

Á¾¾ç ½ºÆ®¸²
- Antibody-Based Therapies
Ç×ü ±â¹Ý ÀǾà - Engineering ADCs
ADC °øÇÐ - Next-Gen Immunotherapies
Â÷¼¼´ë ¸é¿ªÄ¡·á